RxNorm Semantic Concepts Index - 614
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "614".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 614084 | Exjade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 6141 | Ketone | Designated preferred name (PT) | NO | |
| RxCUI: 6141 | Ketone | Full form of descriptor (FN) | NO | |
| RxCUI: 6141 | Ketone | Designated preferred name (PT) | NO | |
| RxCUI: 6141 | Ketone | Full form of descriptor (FN) | NO | |
| RxCUI: 6142 | Ketoprofen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6142 | Ketoprofen | Designated preferred name (PT) | YES | |
| RxCUI: 6142 | Ketoprofen | Full form of descriptor (FN) | YES | |
| RxCUI: 6142 | Ketoprofen | Designated preferred name (PT) | YES | |
| RxCUI: 6142 | Ketoprofen | Full form of descriptor (FN) | YES | |
| RxCUI: 6143 | Ketose | Designated preferred name (PT) | NO | |
| RxCUI: 6143 | Ketose | Full form of descriptor (FN) | NO | |
| RxCUI: 61431 | Deoxyribonucleic acid-3-methyladenine glycosylase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61431 | Deoxyribonucleic acid-3-methyladenine glycosylase II | Full form of descriptor (FN) | NO | |
| RxCUI: 61431 | Deoxyribonucleic acid-3-methyladenine glycosylase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61431 | Deoxyribonucleic acid-3-methyladenine glycosylase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61431 | Deoxyribonucleic acid-3-methyladenine glycosylase II | Designated preferred name (PT) | NO | |
| RxCUI: 614348 | metFORMIN / rosiglitazone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 614348 | metFORMIN / rosiglitazone | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 614348 | metFORMIN / rosiglitazone | Designated preferred name (PT) | YES | |
| RxCUI: 614348 | metFORMIN / rosiglitazone | Full form of descriptor (FN) | YES | |
| RxCUI: 614373 | Deferasirox | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 614373 | Deferasirox | Designated preferred name (PT) | YES | |
| RxCUI: 614373 | Deferasirox | Full form of descriptor (FN) | YES | |
| RxCUI: 614373 | Deferasirox | Designated preferred name (PT) | YES | |
| RxCUI: 614373 | Deferasirox | Full form of descriptor (FN) | YES | |
| RxCUI: 614390 | Increlex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 614391 | abatacept | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 614391 | abatacept | Designated preferred name (PT) | YES | |
| RxCUI: 614391 | abatacept | Full form of descriptor (FN) | YES | |
| RxCUI: 614391 | abatacept | Designated preferred name (PT) | YES | |
| RxCUI: 614391 | abatacept | Full form of descriptor (FN) | YES | |
| RxCUI: 614534 | abacavir / lamiVUDine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 614534 | abacavir / lamiVUDine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 614534 | abacavir / lamiVUDine | Designated preferred name (PT) | YES | |
| RxCUI: 614534 | abacavir / lamiVUDine | Full form of descriptor (FN) | YES | |
| RxCUI: 61455 | mizolastine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 61455 | mizolastine | Designated preferred name (PT) | NO | |
| RxCUI: 61455 | mizolastine | Full form of descriptor (FN) | NO | |
| RxCUI: 61455 | mizolastine | Designated preferred name (PT) | NO | |
| RxCUI: 61455 | mizolastine | Full form of descriptor (FN) | NO | |
| RxCUI: 614593 | Aptivus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 6146 | Ketotifen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6146 | Ketotifen | Designated preferred name (PT) | YES | |
| RxCUI: 6146 | Ketotifen | Full form of descriptor (FN) | YES | |
| RxCUI: 6146 | Ketotifen | Designated preferred name (PT) | YES | |
| RxCUI: 6146 | Ketotifen | Full form of descriptor (FN) | YES | |
| RxCUI: 614653 | Hydrogenated ergot alkaloid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 614654 | metaclazepam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 6147 | Khellin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 6147 | Khellin | Designated preferred name (PT) | NO | |
| RxCUI: 6147 | Khellin | Full form of descriptor (FN) | NO | |
| RxCUI: 61481 | Complex I dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61481 | Complex I dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 61481 | Complex I dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61481 | Complex I dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61481 | Complex I dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61481 | Complex I dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 61481 | Complex I dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61481 | Complex I dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 614833 | Allanzyme | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 614942 | citric acid 66.8 MG/ML / sodium citrate 100 MG/ML [Liqui-Dualcitra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 614943 | citric acid / sodium citrate Oral Solution [Liqui-Dualcitra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 614944 | citric acid 66.8 MG/ML / sodium citrate 100 MG/ML Oral Solution [Liqui-Dualcitra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 614944 | citric acid 66.8 MG/ML / sodium citrate 100 MG/ML Oral Solution [Liqui-Dualcitra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |